FEN1 Protein

protein

FEN1 Protein

<div class=“infobox infobox-protein”>
Protein Name FEN1 Protein
Gene FEN1
UniProt ID P39748
Alternative Names Flap Endonuclease 1, MF1, RAD2
Molecular Weight ~43 kDa
Structure N-terminal domain, intermediate domain, C-terminal helix-hairpin-helix domain
Subcellular Localization Nucleus
</div>

Overview

FEN1 (Flap Endonuclease 1) is a key DNA repair enzyme essential for DNA replication and repair processes[@liu2000]. As a structure-specific nuclease, FEN1 processes flap structures during DNA replication and repair. Dysregulation of FEN1 has been strongly implicated in neurodegeneration, cancer predisposition, and aging[@mastroeni2018].

Molecular Function

DNA Repair Enzymatic Activity

FEN1 possesses multiple enzymatic functions essential for genome stability:

  • Flap endonuclease activity: Cleaves flap structures that form during DNA replication
  • 5’ exonuclease activity: Removes RNA-DNA primers during Okazaki fragment processing
  • 3’ exonuclease activity: Provides proofreading capability

Structure-Function Relationship

FEN1’s catalytic activities are mediated by conserved domains:

  • N-terminal domain: Contains the active site for nuclease activity
  • Intermediate domain: Involved in substrate binding
  • C-terminal helix-hairpin-helix (HhH) domain: Coordinates metal ions for catalysis

Role in Neurodegenerative Diseases

Alzheimer’s Disease

FEN1 dysfunction significantly contributes to Alzheimer’s disease pathogenesis:

  1. DNA Damage Accumulation: Impaired FEN1 activity leads to accumulation of DNA damage in neurons, accelerating neurodegeneration[@mastroeni2018]. Neurons are particularly vulnerable due to their post-mitotic state.

  2. Genomic Instability: FEN1 deficiency promotes chromosomal instability that may contribute to tau pathology and neuronal dysfunction.

  3. Cell Cycle Re-entry: DNA damage signaling due to FEN1 dysfunction can trigger inappropriate cell cycle re-entry in neurons, leading to apoptosis.

  4. Mitochondrial Dysfunction: FEN1 mutations affect mitochondrial DNA repair, compounding mitochondrial dysfunction in AD.

Parkinson’s Disease

In Parkinson’s disease, FEN1 plays a protective role:

  1. Dopaminergic Neuron Survival: FEN1 activity is crucial for maintaining genomic integrity in dopaminergic neurons, which are particularly vulnerable to oxidative stress.

  2. α-Synuclein Interactions: DNA damage can promote α-synuclein aggregation, and FEN1 dysfunction may accelerate this process[@wong2019].

  3. Mitochondrial DNA Repair: FEN1 deficiency in mitochondria promotes accumulation of mitochondrial DNA mutations in dopaminergic neurons.

Amyotrophic Lateral Sclerosis

FEN1 involvement in ALS includes:

  1. Motor Neuron Vulnerability: FEN1 dysfunction exacerbates DNA damage accumulation in motor neurons.

  2. Oxidative Stress: The high metabolic demand of motor neurons makes them particularly sensitive to FEN1 deficiency under oxidative stress conditions.

  3. RNA Processing: FEN1’s role in processing R-loops may affect RNA metabolism relevant to TDP-43 pathology.

DNA Damage Response in Neurodegeneration

FEN1 sits at the nexus of DNA damage response and neurodegeneration:

  1. DNA Damage Signaling: FEN1 deficiency activates DNA damage response pathways including p53, ATM/ATR
  2. Apoptosis: Persistent DNA damage triggers neuronal apoptosis through multiple pathways
  3. Cellular Senescence: FEN1 dysfunction can promote cellular senescence in supporting glial cells

Cancer Predisposition

FEN1 mutations cause cancer predisposition syndromes:

  1. FEN1 Mutations: Certain FEN1 variants increase cancer risk, particularly breast and ovarian cancer
  2. Genome Instability: FEN1 deficiency promotes mutagenic DNA repair
  3. Therapeutic Implications: FEN1-targeting therapies show promise in cancer treatment

Therapeutic Targeting

FEN1-based therapeutic strategies include:

  1. DNA Repair Enhancement: Developing FEN1 activators to enhance DNA repair in neurons
  2. Synthetic Lethality: Exploiting FEN1 deficiency in cancer therapy
  3. Neuroprotection: Small molecules that compensate for FEN1 dysfunction

Research Directions

Key research areas include:

  • Understanding FEN1 regulation in post-mitotic neurons
  • Developing FEN1 activity modulators
  • Biomarker development for DNA repair deficiency
  • Clinical translation of neuroprotective strategies

See Also

External Links

References

  1. Liu Y, et al., Human FEN1: structure, function, and application in DNA repair. Gene. 2000 (2000)
  2. Mastroeni D, et al., DNA damage in Alzheimer’s disease and neurodegeneration. Journal of Alzheimer’s Disease. 2018 (2018)
  3. Wong A, et al., Alpha-synuclein and DNA damage: a vicious cycle in Parkinson’s disease. Brain Research. 2019 (2019)
  4. Unknown, Caldecott KW. DNA single-strand break repair and neurodegeneration. DNA Repair. 2004 (2004)